Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 21 - Drugs for disorders of the muscular or neuromuscular system
Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
09/2010
09/02/2010US20100222270 Heterocyclic compounds as crth2 receptor antagonists
09/02/2010US20100222254 Stabilization of clostridium botulinum neurotoxin complex
09/02/2010US20100221331 Pharmaceutical compositions comprising colloidal silicon dioxide
09/01/2010EP2223922A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta
09/01/2010EP2223703A1 External preparation composition comprising fatty acid-based ionic liquid as active ingredient
09/01/2010EP1423406B1 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina)
09/01/2010CN101816720A Bonesetting and collaterals activating pills
09/01/2010CN101081865B Abstraction of pilose antler releasing somatomedin (DEER GHRF) and preparation method thereof
08/2010
08/31/2010US7785599 Albumin fusion proteins
08/31/2010US7785587 Mixture of corticosteroid and transforming growth factor inhibitor
08/26/2010WO2010095663A1 Fused heterocyclic ring compound
08/26/2010US20100216887 Intrathecal baclofen pharmaceutical dosage forms with fewer degradation products
08/26/2010US20100216880 Transdermal compositions for anticholinergic agents
08/26/2010US20100216871 Use of compounds having ccr antagonism
08/26/2010US20100216752 Use as medicaments of derivatives of cholest-4-en-3-one, pharmaceutical compositions containing them, novel derivatives and their preparation process
08/26/2010US20100216712 Nucleic acid codifying for a utrophin transcription specific regulating protein, protein codified thereby and uses thereof
08/26/2010US20100215761 Composition for regulating lipid metabolism
08/26/2010US20100215661 Nicotinamide derivates useful as p38 inhibitors
08/26/2010US20100215657 Methods and Compositions Using Klotho-FGF Fusion Polypeptides
08/26/2010US20100215652 Nicotinamide derivates useful as p38 inhibitors
08/25/2010EP2221047A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
08/25/2010EP1469882B1 Treatment of nervous system diseases with goat serum
08/25/2010EP1339402B1 Azaphenanthridone derivatives and their use as parp inhibitors
08/25/2010EP1042286B1 Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith
08/25/2010CN201558332U Arthritis black plaster
08/25/2010CN101815535A molecules for targeting compounds to various selected organs or tissues
08/25/2010CN101810817A Formula of Chinese medicament for treating myasthenia of limbs
08/25/2010CN101810808A Chinese medicinal composition for treating tremor and preparation method thereof
08/25/2010CN101810709A Medicament for treating rheumatism
08/25/2010CN101810644A Production method of ant essential oil and ant oil soft capsule
08/25/2010CN101041626B Tetrafluorobenzyl derivatives and pharmaceutical composition containing same
08/24/2010US7781440 Neurodegenerative diseases caused by GSK3 such as Alzheimer's disease
08/24/2010CA2507749C Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
08/24/2010CA2322716C Use of follistatin to modulate gdf-8 and bmp-11
08/19/2010WO2010093784A2 Modified virus vectors and methods of making and using the same
08/19/2010WO2010093322A1 Methods for identifying therapeutic agents modulating activity of the igf2 repressor zbed6
08/19/2010WO2010092966A1 Novel triazine derivative and pharmaceutical composition containing same
08/19/2010WO2010075263A3 Compounds and methods for enhancing erythropoiesis
08/19/2010US20100210685 Novel Substituted Indoles
08/19/2010US20100210638 Modulators of atp-binding cassette transporters
08/19/2010US20100210637 Heteroaryloxy nitrogenous saturated heterocyclic derivative
08/19/2010US20100210624 Aryloxy- and heteroaryloxy-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
08/19/2010US20100209529 Pharmacologic-functioning water and usage of the same
08/19/2010US20100209507 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
08/19/2010US20100209442 Deglycosylated and desialidated long pentraxin ptx3
08/19/2010US20100209408 Remodeling of Tissues and Organs
08/19/2010CA2752269A1 Novel triazine derivative and pharmaceutical composition comprising the same
08/19/2010CA2751581A1 Compositions and methods for extended therapy with aminopyridines
08/18/2010EP2218337A1 Mimicking the metabolic effects of caloric restriction by administration of glucose anti-metabolites
08/17/2010US7776898 Opioid receptor active compounds
08/17/2010US7776895 Inhalation devices for delivering phenethanolamine derivatives for the treatment of respiratory diseases
08/17/2010US7776890 1H-indazole compounds
08/17/2010US7776854 1,3-benzothiazol-2-yl(2-{[4-(morpholin-4-ylmethyl)benzyl]oxy}pyrimidin-4-yl)-acetonitrile; (or benzimidazole or benzoxazole 2-acetonitrile derivatives); systemic sclerosis, CREST, sine scleroderma, cirrhosis, heart failure; inhibitors of JNK (c-Jun N-terminal Kinases)
08/17/2010US7775469 treatment of conditions characterized by a need to modulate migratory-cell movement associated with specific sites in a subject; isolating a stromal-cell-derived fugetactic agent
08/17/2010CA2481535C Use of ep4 receptor ligands in the treatment of il-6 involved diseases
08/17/2010CA2471762C Cell-permeable peptide inhibitors of the jnk signal transduction pathway
08/12/2010WO2010050802A3 Methods and means for efficient skipping of at least one of the following exons of the human duchenne muscular dystrophy gene: 43, 46, 50- 53.
08/12/2010WO2007019344A8 Imidazo [2,1-b] thiazole derivatives as sirtuin modulating compounds
08/12/2010US20100204212 Fused heterocyclic compounds useful as kinase modulators
08/12/2010US20100204184 Phosphonates useful as modulators of T-gamma-9-delta-2 activity
08/12/2010US20100204171 Materials and methods for treating diseases caused by genetic disorders using aminoglycosides and derivatives thereof which exhibit low nephrotoxicity
08/12/2010US20100203628 Novel modified galectin 9 proteins and use thereof
08/12/2010US20100203542 Method for treating autoimmune diseases and screening method for preventive or therapeutic agent for the same
08/12/2010US20100203090 Enteric coated, soluble creatine and polyethylene glycol composition for enhanced skeletal uptake of oral creatine
08/12/2010US20100203016 Pregnancy hormone combination for treatment of autoimmune diseases
08/12/2010CA2751489A1 Dual targeting of mir-208 and mir-499 in the treatment of cardiac disorders
08/11/2010EP2216409A1 Albumin fusion proteins
08/11/2010EP2216032A1 Utilization of carbon dioxide-supplying unit for muscle strengthening and method of increasing cattle meat thereby
08/11/2010EP2215074A1 Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
08/11/2010EP1135415B1 Humanized antibodies to gamma-interferon
08/11/2010CN101798306A Uncaria alkaloid monomer as well as preparation method and application thereof
08/10/2010US7772260 Neuroprotectants; reduce side effect of neurotoxic agent; treatment of neuropathies resulting from chemotherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases, neurodegenerative diseases
08/10/2010US7772249 Imidazo[1,2-b]pyridazine compound
08/05/2010WO2010087313A1 Neurite elongation stimulator
08/05/2010WO2010087306A1 Anti-neurodegenerative disease agent
08/05/2010WO2010087244A1 Cyclic amino alcohol compound
08/05/2010WO2010086040A1 Pyrazolo-pyrimidines for treatment of duchenne muscular dystrophy
08/05/2010US20100197917 Coumarin derivatives useful as tnf alpha inhibitors
08/05/2010US20100197907 Phosphorus-containing compounds & uses thereof
08/05/2010US20100197705 Quinazolinone Derivatives Useful as Vanilloid Antagonists
08/05/2010US20100197579 Corticotropin Releasing Factor 2 Receptor Agonists
08/05/2010US20100196472 Modified release compositions of milnacipran
08/05/2010US20100196399 LDL Receptor-Related Proteins 1 and 2 and Treatment of Bone or Cartilage Conditions
08/04/2010EP2213743A1 Albumin fusion proteins
08/04/2010EP2213738A2 siRNA molecules targeting Bcl-2
08/04/2010EP2212285A1 N-acylhydrazone derivatives useful as modulators of nicotinic acetylcholine receptors
08/04/2010EP1429750B1 Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto
08/04/2010CN101796074A Anti-notch1 NRR antibodies and methods using same
08/04/2010CN101791150A Production method of silica gel sheet containing traditional Chinese medicines and being used for the health underpants
08/03/2010CA2444269C Treatment of disorders secondary to organic impairments
08/03/2010CA2402199C Amidino compounds useful as nitric oxide synthase inhibitors
07/2010
07/29/2010WO2010084999A1 Immunosuppressive agents and prophylactic and therapeutic agents for autoimmune diseases
07/29/2010US20100190964 Antibodies to human ErbB4
07/29/2010US20100190733 Methods of Treating Muscular Dystrophies
07/29/2010US20100189782 Compositions Comprising Carisoprodol and Methods of Use Thereof
07/29/2010US20100189704 Dietary supplement enhancing the muscular energy metabolism, comprising an alkanoyl carnitine and ribose
07/29/2010US20100189686 Albumin Fusion Proteins
07/28/2010EP2210956A2 Method to inhibit cell growth using oligonucleotides
07/28/2010EP1458392B9 Acridones as inhibitors of impdh enzyme
07/28/2010CN101790385A Molecules for targeting compounds to various selected organs, tissues or tumor cells
1 ... 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 ... 233